… and how the decisions are made

Gabriel M. Danovitch, Alan Wilkinson, J. Thomas Rosenthal, Michael W. Zimecki, Charles Levenback, Elmer Pader, Ruth Hubbard, Stephen D. Boren

Research output: Contribution to journalLetter

Abstract

To the Editor: We have some pretty tough days too, for in addition to the clinical, academic, and administrative functions that are part of our careers, we now have to spend many hours persuading health insurance companies that we are not trying to manipulate them into paying more money than Medicare does for kidney transplants, as Dr. Boren insinuates (Feb. 17 issue)1. He is making his work unnecessarily difficult by equating understandably difficult decisions about whether to approve autologous bone marrow transplantation for patients with metastatic breast cancer with decisions about approval of predialysis transplantation for patients with end-stage.

Original languageEnglish (US)
Pages (from-to)331-332
Number of pages2
JournalNew England Journal of Medicine
Volume331
Issue number5
DOIs
StatePublished - Aug 4 1994

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of '… and how the decisions are made'. Together they form a unique fingerprint.

  • Cite this

    Danovitch, G. M., Wilkinson, A., Rosenthal, J. T., Zimecki, M. W., Levenback, C., Pader, E., Hubbard, R., & Boren, S. D. (1994). … and how the decisions are made. New England Journal of Medicine, 331(5), 331-332. https://doi.org/10.1056/NEJM199408043310515